Cass, This is certainly no threat to BrachySil which is to be PSD's main source of revenue in the coming years. TDS appears to be just an improvement on existing transdermal patches. IMO nothing has been demonstrated from this that would compete with PSDs proposed products. However, you cant rule this out. Like psd, they are interested in developing delivery methods that potentially could extend patent life of drugs. 10 years from now, who knows!
- Forums
- ASX - By Stock
- PSD
- tds technology
PSD
psivida limited
tds technology, page-2
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated